Hyloris Pharmaceuticals Eulerpool News

Hyloris Pharmaceuticals Eulerpool News

Hyloris Pharmaceuticals Aktie News

Hyloris Pharmaceuticals wird von vielen Journalisten und Investoren weltweit beobachtet. Die aktuellsten Hyloris Pharmaceuticals News stellen wir hier zusammen.

• 14. März ·

  Yahoo
  Hyloris Reports Full Year Results for 2023 & Provides Business Outlook
• 14. März ·

  Yahoo
  Communication at the request of the FSMA on the transactions with Qliniq
• 8. März ·

  Yahoo
  Hyloris to Report 2023 Full-Year Results on 14 March 2024
• 27. Februar ·

  Yahoo
  Hyloris Announces Launch of Maxigesic® IV in the U.S. and approval In Canada
• 14. Februar ·

  Yahoo
  Hyloris Enrolls First Patient in Phase 3 Clinical Trial for its Proprietary Mouth Rinse to Control Incidences of Bleeding Related to Dental Procedures
• 30. Januar ·

  Yahoo
  Hyloris and Purna Female Healthcare Announce Positive Results from Phase 2 Trial in Patients with Acute Vulvovaginal Candidiasis (VVC)
• 18. Januar ·

  Yahoo
  Hyloris Broadens Pipeline with new Product Candidate for Vulvar Lichen Sclerosus (VLS)
• 16. Januar ·

  Yahoo
  Orphan Drug Designation Granted to PTX-252 by U.S. FDA for the Treatment of Acute Myeloid Leukaemia (AML)
• 16. Januar ·

  Yahoo
  Pleco Therapeutics receives FDA Orphan Drug Designation
• 26. Dezember ·

  Yahoo
  Hyloris Announces Positive Clinical Study Results for Valacyclovir Oral Suspension (HY-029)